Radioactive materials: Winning the battle against cancer [abstract]

MOspace/Manakin Repository

Breadcrumbs Navigation

Radioactive materials: Winning the battle against cancer [abstract]

Please use this identifier to cite or link to this item: http://hdl.handle.net/10355/643

[+] show full item record


Title: Radioactive materials: Winning the battle against cancer [abstract]
Author: Lane, Stephanie R., 1982-
Contributor: University of Missouri-Columbia. Office of Undergraduate Research
Keywords: radiopharmaceuticals
cancer
Rhenium (Re)
molecular cage
Date: 2004
Publisher: University of Missouri--Columbia. Office of Undergraduate Research
Abstract: Radiopharmaceuticals are drugs containing a radioactive atom that can be used for the treatment of certain cancers. The radiopharmaceuticals we are interested in consist of a radioactive source contained in a molecular cage and are directed to specific sites in the body via a targeting molecule. Rhenium (Re) is a useful radioactive source that can effectively kill surrounding cells with the energy it emits. It is important for the radioactive source to be secured in the molecular cage so that it will not irradiate unwanted parts of the body. A radiopharmaceutical that will more effectively irradiate the tumor may require fewer testaments, less overall discomfort, and will hopefully result in a lower cost for patients. The focus of this study was to design the cage that would effectively hold Re. Once Re was contained in the cage it was reacted with phosphine to increase its stability. Characterization methods were employed to insure that the structure had formed, but further characterization is needed. If determined stable, radioactive Re will be tested for stability in rat serum.
URI: http://hdl.handle.net/10355/643

This item appears in the following Collection(s)

[+] show full item record